Eaton T, Young P, Nicol K, Kolbe J
Green Lane Respiratory Services, Auckland City Hospital, New Zealand.
Chron Respir Dis. 2006;3(1):3-9. doi: 10.1191/1479972306cd077oa.
The endurance shuttle walk test (ESWT) is a standardized externally controlled constant paced field test for the assessment of endurance capacity in chronic lung disease. The ESWT has been advocated as a simple, acceptable, repeatable and responsive outcome measure for COPD patients undergoing pulmonary rehabilitation, but has not been formally compared with the more commonly used field walking test, the six-minute walk (6MW). We aimed to determine: 1) the responsiveness of the ESWT in COPD patients attending a hospital-based pulmonary rehabilitation programme, and 2) to compare the responsiveness of the ESWT with the 6MW.
Consecutive COPD patients, referred for a standard 8 week pulmonary rehabilitation programme, were recruited. Outcome parameters studied at baseline and completion of rehabilitation programme (8 weeks) included spirometric lung volumes, resting oxygen saturation, breathlessness scored pre and post exercise (modified Borg dyspnoea score), 6MW, ESWT, health-related quality of life (Chronic Respiratory Questionnaire) and Hospital Anxiety and Depression (HAD) scale. The incremental shuttle was employed to predict VO2 peak; 85% VO2 peak was used to determine the walk speed for the ESWT.
Twenty stable COPD patients (11 male), mean (SD), age 71, (9) FEV1 0.95 (0.51), resting SpO2 95% (2) 6MW distance (m) 351 (104) and ESWT distance (m) 313 (193) were studied. Three patients did not complete their rehabilitation programme. Following rehabilitation, there were significant improvements in 6MW, ESWT, total CRQ and anxiety domain (HAD). The 6MW distance increased by 17% (47 m 95%CI 3, 90), while the ESWT increased by 92% (302 m 95%CI 104, 501).
The ESWT is a simple, acceptable and highly responsive outcome measure for COPD patients undergoing a pulmonary rehabilitation programme. The ESWT has potential advantages in that it may be more responsive than the 6MW.
耐力穿梭步行试验(ESWT)是一项标准化的、外部控制的、恒定步速的现场试验,用于评估慢性肺病患者的耐力。ESWT被认为是一种简单、可接受、可重复且能反映变化的结局指标,适用于接受肺康复治疗的慢性阻塞性肺疾病(COPD)患者,但尚未与更常用的现场步行试验——六分钟步行试验(6MW)进行正式比较。我们旨在确定:1)ESWT在参加以医院为基础的肺康复计划的COPD患者中的反应性;2)比较ESWT与6MW的反应性。
招募连续的COPD患者,他们被转介参加标准的8周肺康复计划。在基线和康复计划完成时(8周)研究的结局参数包括肺量计测定的肺容积、静息氧饱和度、运动前后的呼吸困难评分(改良Borg呼吸困难评分)、6MW、ESWT、健康相关生活质量(慢性呼吸问卷)和医院焦虑抑郁量表(HAD)。使用递增穿梭试验预测最大摄氧量(VO2峰值);85%的VO2峰值用于确定ESWT的步行速度。
研究了20例稳定的COPD患者(11例男性),平均(标准差)年龄71岁,(9)第一秒用力呼气容积(FEV1)0.95(0.51),静息血氧饱和度(SpO2)95%(2),6MW距离(米)351(104),ESWT距离(米)313(193)。3例患者未完成康复计划。康复后,6MW、ESWT、慢性呼吸问卷总分和焦虑领域(HAD)有显著改善。6MW距离增加了17%(47米,95%可信区间3,90),而ESWT增加了92%(302米,95%可信区间104,501)。
ESWT是接受肺康复计划的COPD患者的一种简单、可接受且反应性高的结局指标。ESWT具有潜在优势,因为它可能比6MW更具反应性。